Clinical Trial

Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer

Study acronym: PostOP HYPOCxE
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate a shorter course of postoperative pelvic radiotherapy in patients with cervical and endometrial cancer. The standard radiotherapy schedule usually requires many treatment sessions over several weeks, which can be burdensome for patients and may affect their ability to complete treatment. This study will compare a shorter radiotherapy schedule (hypofractionated radiotherapy) with the standard schedule. Both treatments deliver a similar total radiation dose, but the shorter schedule reduces the number of hospital visits and overall treatment time. Participants will be randomly assigned to receive either the shorter or standard radiotherapy after surgery. The study will evaluate side effects, treatment effectiveness, and quality of life. The goal is to determine whether the shorter treatment is as safe and effective as the standard approach.
Trial Details
NCT Number NCT07595224
Lead Sponsor Siriraj Hospital
Conditions Endometrial Cancer, Cervix Cancer
Enrollment 120 participants
Start Date 2026-03-11
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-19